Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | MMP2 | P08253 | 2/20 | 0.56 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8121816 | 0.96 | PTGS2 (0.71) | PTGS2PTGS1CYP2C9MMP2PDPK1 | |
| SCHEMBL8118945 | 0.91 | PTGS2 (0.73) | PTGS2PTGS1CYP2C9MMP2PDPK1 | |
| SCHEMBL8423279 | 0.90 | PTGS2 (0.72) | PTGS2PTGS1CYP2C9CHRNA7 | |
| SCHEMBL212707 | 0.89 | PTGS2 (0.80) | PTGS2PTGS1CYP2C9MMP2PDPK1 | |
| SCHEMBL8112778 | 0.89 | PTGS2 (0.80) | PTGS2PTGS1CYP2C9PDPK1CHRNA7 | |
| SCHEMBL8112204 | 0.89 | PTGS2 (0.80) | PTGS2PTGS1CYP2C9PDPK1CHRNA7 | |
| SCHEMBL5698697 | 0.88 | PTGS2 (0.88) | PTGS2PTGS1CYP2C9PDPK1CHRNA7 | |
| SCHEMBL8128434 | 0.88 | PTGS2 (0.69) | PTGS2PTGS1CYP2C9MMP2PDPK1 | |
| SCHEMBL8122528 | 0.88 | PTGS2 (0.69) | PTGS2PTGS1CYP2C9MMP2PDPK1 | |
| SCHEMBL8119016 | 0.88 | PTGS2 (0.72) | PTGS2PTGS1CYP2C9MMP2PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731796-B1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0731796-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-09-18 | — | — | EP | disclosed |
| US-5434178-A | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation | G.D. SEARLE & CO. (US) | 1995-07-18 | — | — | US | disclosed |
| WO-1995015318-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | disclosed |